Market Newsdesk

Protolabs Announces CEO Succession Plan

MAPLE PLAIN, Minn.–(BUSINESS WIRE)–
Proto Labs, Inc. (NYSE: PRLB), a leading online and technology-enabled, on-demand manufacturer, today announced that its Board of Directors has unanimously elected Robert Bodor to succeed Vicki Holt as the company’s President and Chief Executive Officer effective March 1, 2021. Vicki Holt is retiring after leading the company for the past seven years. Holt will remain CEO during this transition time and continue to serve on the board through May 2021.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201214005198/en/

“I am excited to announce that the Protolabs Board of Directors has named Rob as our next CEO,” said Holt. “Rob has been instrumental in building Protolabs into what it is today. Since joining the company, Rob has held a variety of leadership roles, including overseeing our largest region since 2015. He has more than doubled the revenue of the Americas’ business during his tenure and played an instrumental role in expanding the company’s services into 3D printing and sheet metal fabrication. Rob is a very strategic business leader and a great leader of people. His passion and commitment will continue to serve Protolabs well.”

Bodor, with more than 20 years of leadership experience, has served as Protolabs’ Vice President and General Manager of the Americas for the past six years. During his tenure at Protolabs, he has also served as Chief Technology Officer and leader of the company’s business development and product development functions. Before joining Protolabs in 2012, Bodor held progressive leadership roles at Honeywell and McKinsey.

“I look forward to the opportunity to serve our employees, our customers, and our shareholders,” said Bodor. “I want to thank Vicki for her support and guidance over the past seven years, and I am excited about Protolabs’ future and what we can accomplish. I am fortunate to have the opportunity to lead the world’s foremost digital manufacturing service provider that’s helping accelerate product innovation and supply chain optimization across many industries. My commitment is to inspire our incredible team of employees and deliver value for our customers and shareholders. I look forward to working with Protolabs’ executive team as we continue to drive the success of this company.”

Archie Black, Protolabs’ Chairman of the Board, added, “The Protolabs board is excited about what Rob brings to the CEO role. This transition follows a carefully planned succession process and Rob is the right person to lead the company. He has a track record of outstanding performance with great people leadership throughout his career. The board congratulates Rob on his promotion and we look forward to working with him in this new capacity.”

Black continued, “We also want to extend our thanks to Vicki for her exceptional leadership as CEO over the last seven years. It has been a period of remarkable growth and expansion for Protolabs. She continuously improved all aspects of the company’s operations while being a compassionate leader and developing a winning culture. All of this helped drive exceptional revenue growth and returns for our shareholders. Protolabs’ revenue increased by more than 165 percent and market capitalization grew by more than $1.8 billion during her leadership. We congratulate Vicki on her outstanding performance and thank her for building Protolabs into a world-class organization.”

About Protolabs

Protolabs is the world’s leading source for digital manufacturing services. The technology-enabled company produces custom components in as fast as 1 day with automated 3D printing, CNC machining, sheet metal fabrication, and injection molding processes. Its digital approach to manufacturing enables accelerated time to market, reduces manufacturing costs, and enables supply chain agility throughout the product life cycle. Visit protolabs.com for more information.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201214005198/en/

Investor Relations Contact

Protolabs

Dan Schumacher, 763-479-7240

Director of Investor Relations

[email protected]

Media Contact

Protolabs

Will Martin, 763-479-7719

Sr. Marketing Communications Manager

[email protected]

KEYWORDS: Minnesota United States North America

INDUSTRY KEYWORDS: Other Manufacturing Technology Steel Engineering Manufacturing Software Internet Hardware Electronic Design Automation

MEDIA:

Logo

Photo

Vicki Holt, President & CEO, Protolabs (Photo: Business Wire)

Photo

Rob Bodor, VP & GM, Americas, Protolabs (Photo: Business Wire)

Agilent Receives Multiple Innovation Awards

Agilent products selected for The Analytical Scientist Innovation Awards 2020

SANTA CLARA, Calif.–(BUSINESS WIRE)–Agilent Technologies Inc. (NYSE: A) today announced that both the NanoDis System and the innovative new style polychromator in the 5800 and 5900 ICP-OES have received Innovation Awards from The Analytical Scientist.

The recently launched NanoDis System utilizes cross-flow filtration—a concept traditionally used in industrial process chemistry—combined with conventional dissolution instruments to enable nanoparticle dissolution testing. Along with the introduction of automation for the complete workflow, the novel new system improves the process of introducing new drugs to market.

“The overwhelmingly positive response for the NanoDis System from the dissolution community has been quite remarkable,” said Michael Frank, associate vice president of global marketing, Agilent Liquid Phase Separation Division. “At Agilent, we strive to deliver products that support scientists and their need to prove reliable results in an efficient and effective way, which is exactly what the NanoDis System delivers.”

Design changes to the Agilent ICP-OES polychromator have improved the analytical performance of the latest Agilent ICP-OES instruments released earlier this year by lowering detection limits and improving spectral resolution. This modernization has not only improved the performance of the instrument but has also dramatically reduced the footprint and Argon gas consumption, making it a more sustainable option for laboratories.

“The new design of the polychromator is a real game-changer for our ICP-OES instruments moving forward, raising the bar for elemental analysis,” commented Keith Bratchford, vice president and general manager, Agilent Spectroscopy. “Receiving an Innovation Award from The Analytical Scientist is a testament to the great work that our R&D teams do, striving to continually find ways to improve the performance of our instruments.”

Through advancements like these, including Agilent’s Vaya Raman spectrometer for pharma QA/QC, which as well as being a gold winner in the R&D 100 awards, is also a finalist in The Medicine Maker’s Innovation Awards, Agilent is enacting its commitment to advancing the quality of life and progressing science. Agilent instruments and technologies help scientists to further disease research, develop advanced therapies, and ensure our water, food, air, and fuels are clean. The discoveries Agilent enables makes the world a better place to live.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics, and applied chemical markets, delivering insight and innovation toward improving the quality of life. Agilent instruments, software, services, solutions, and people provide trusted answers to customers’ most challenging questions. The company generated revenue of $5.34 billion in fiscal 2020 and employs 16,400 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn, Twitter, and Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201214005178/en/

Catherine Kaye

Agilent Technologies

+44 (0)7775 410632

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Electronic Design Automation Technology Software Research Science Hardware

MEDIA:

Logo

Blue Apron Introduces “Wellness 360” Campaign

Initiative to Include New Menu Offerings, Advertising and Collaborations

NEW YORK–(BUSINESS WIRE)–
Blue Apron Holdings, Inc. (NYSE: APRN) today introduced its newest campaign, Wellness 360. As part of this initiative, the company will showcase how home cooking can benefit holistic wellness, including physical, brain, relationship, mental and financial health.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201214005166/en/

“As our community of home cooks continue to be increasingly focused on their overall wellness, we designed Wellness 360 to expand the ways in which cooking with Blue Apron can support them on that journey,” said Dani Simpson, Blue Apron’s Head of Brand and Marketing. “We know home cooking is more than making a meal. It has the ability to unlock a host of different benefits across aspects of one’s daily life, including reducing stress.”

As part of the initial Wellness 360 launch, Blue Apron introduced:

• New recipes to offer additional flexibility and balance: The new Wellness menu features recipes with fresh produce, whole grains, high-quality proteins and natural sweeteners. These nutritionist-approved recipes are a complement to Blue Apron’s Signature menu, giving customers flexibility to choose meals that fit their lifestyles without sacrificing the flavor they know and love.

• Expansion of Blue Apron’s current offerings: The company is continuing to deliver on its promise to add flexibility and variety on its menu by expanding its customization offerings. With a new “Swap the Starch” option, customers can swap out a traditional side starch like potatoes, rice or pasta in a recipe for additional vegetables, Banza chickpea pasta or “make your own cauliflower rice.”

• Cooking with less prep and easier cleanup: Blue Apron also plans to offer home cooks the option to choose recipes designed for quicker prep and easier clean-up, like sheet pan and one-pot dinners, so they can spend less time in the kitchen.

• Advertising and influencer campaign: Wellness 360 is a fully integrated campaign and the company plans to feature content across multiple channels, including connected TV, streaming video and editorial sponsorships. Blue Apron also expects to work with influencers across all five wellness categories to highlight the many ways home cooking can support a holistic healthy lifestyle.

• Collaborations that bring the campaign to life: In celebration of Disney and Pixar’s new movie Soul, streaming on Disney+ starting on December 25, Blue Apron chefs created new wholesome recipes designed to easily engage kids in the kitchen for the perfect dinner and a movie experience at home. In addition, Blue Apron will continue to work with WW (formerly Weight Watchers) to offer WW-Approved, veggie-forward recipes.

With this renewed focus, the company also updated its vision and mission to reinforce its belief in the transformative power of cooking. Blue Apron’s new vision is “better living through better food” as they work to “spark discovery, connection and joy through cooking.”

To learn more about Blue Apron’s approach to wellness, visit: http://blog.blueapron.com/cooking-at-home-health-wellness.

About Blue Apron

Blue Apron’s vision is “better living through better food.” Launched in 2012, Blue Apron offers fresh, chef-designed recipes that empower home cooks to embrace their culinary curiosity and challenge their abilities to see what a difference cooking quality food can make in their lives. Through its mission to spark discovery, connection and joy through cooking, Blue Apron continuously focuses on bringing incredible recipes to their customers, while minimizing its carbon footprint, reducing food waste, and promoting diversity and inclusion.

Forward Looking Statements

This press release includes statements concerning Blue Apron Holdings, Inc. and its future expectations, plans and prospects that constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. For this purpose, any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. In some cases, you can identify forward-looking statements by terms such as “may,” “should,” “expects,” “plans,” “forecasts,” “anticipates,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential,” or “continue,” or the negative of these terms or other similar expressions. Forward-looking statements in this press release include, but are not limited to, statements relating to the Company’s plans to roll out new product offerings and the timing thereof. The Company’s expectations and beliefs regarding these matters may not materialize, and actual results are subject to risks and uncertainties that could cause actual results to differ materially from those projected. Factors that could contribute to such differences include, without limitation, the continued sufficiency of the company’s cash resources; its ability to effectively manage expenses and cash flows, and its ability to remain in compliance with the financial and other covenants under the company’s indebtedness; its ability, including the timing and extent, to sufficiently manage costs and to fund investments in operations from cash from operations or additional financings in amounts necessary to continue to support the execution of the company’s growth strategy; its ability, including the timing and extent, to successfully execute the company’s growth strategy, cost-effectively attract new customers and retain existing customers, continue to expand its direct-to-consumer product offerings and continue to benefit from the implementation of operational efficiency practices; its ability to sustain the increased demand resulting from the COVID-19 pandemic and to retain new customers; any material and adverse impact of the COVID-19 pandemic on the company’s operations and results, including as a result of the company’s inability to meet demand due to loss of adequate labor, whether as a result of heightened absenteeism or challenges in recruiting and retention or otherwise, prolonged closures, or series of temporary closures, of one or more fulfillment centers and supply chain or carrier interruptions or delays; achieving its expectations regarding the benefits and expected costs and charges associated with temporarily reopening its Arlington fulfillment center; its expectations regarding, and the stability of, its supply chain, including potential shortages or interruptions in the supply or delivery of ingredients, as a result of COVID-19 or otherwise; its ability to accommodate general changes in consumer tastes and preferences or in consumer spending; its ability to comply with modified or new laws and regulations applying to its business; risks resulting from its vulnerability to adverse weather conditions, natural disasters and public health crises, including pandemics; and other risks more fully described in the company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2020 filed with the Securities and Exchange Commission (“SEC”) on October 29, 2020, and in other filings that the company may make with the SEC in the future. The company assumes no obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201214005166/en/

Blue Apron

Investor Contact

[email protected]

Joseph Jaffoni, Richard Land, James Leahy

JCIR

[email protected] or 212-835-8500

Media Contact

Muriel Lussier

Blue Apron

[email protected]

KEYWORDS: New York United States North America

INDUSTRY KEYWORDS: Food/Beverage Retail

MEDIA:

Logo

Photo

Blue Apron launches new “Wellness 360” campaign that focuses on the benefits of home cooking on holistic health. (Photo: Business Wire)

Photo

Blue Apron launches new “Wellness 360” campaign that focuses on the benefits of home cooking on holistic health. (Photo: Business Wire)

Axonics^® Announces Appointment of David M. Demski to Board of Directors

IRVINE, Calif.–(BUSINESS WIRE)–
Axonics Modulation Technologies, Inc. (Nasdaq: AXNX), a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation (SNM) devices for the treatment of urinary and bowel dysfunction, today announced the appointment of veteran medical technology industry executive David M. Demski to its board of directors, effective January 1, 2021.

Mr. Demski currently serves as president and CEO of Globus Medical, Inc. (Nasdaq: GMED), a publicly traded medical technology company that manufactures and markets musculoskeletal implants and related surgical products, with sales in 2019 of over $750 million and a current market capitalization of over $5.9 billion. Mr. Demski has served as a member of the Globus board of directors since the inception of Globus in 2003. From 2003 until his appointment as CEO of Globus in 2017, Mr. Demski held various senior management positions at Globus, including chief financial officer, chief operating officer and president, Emerging Technologies. Mr. Demski received a B.S. in Business Administration from University of Michigan and an M.B.A. from Stanford Graduate School of Business.

Juliet Tammenoms Bakker, managing director at venture capital firm Longitude Capital, has retired from the board of directors effective December 11, 2020. Erik Amble, chairman of Swiss-based NeoMed Management and a founding venture capital investor in Axonics, will be retiring from the board effective December 31, 2020.

Mr. Demski said, “Axonics has done an outstanding job of executing on its business plan since the launch of its r-SNM product in the U.S. a year ago and I admire the company’s commitment to innovation for the benefit of patients, their families and clinicians. Axonics’ technology advantage, distribution footprint and strong balance sheet provides the strategic foundation for significant future growth given the highly underpenetrated market for patients suffering from pelvic floor dysfunction. I am looking forward to serving on the board and working with the Axonics senior leadership team in the months and years ahead.”

Raymond W. Cohen, CEO of Axonics, said, “We are thrilled to welcome Dave to our board of directors. He has extensive leadership experience in medical devices and a proven track record of successfully acquiring and scaling emerging growth businesses. We look forward to benefiting from Dave’s strategic insight as Axonics continues to execute on its ambitious growth objectives.”

Mr. Cohen continued, “We are grateful for the support and board service of Mr. Amble and Ms. Bakker, both of whom shared our vision of developing and commercializing a long-lived SNM device with the potential to change the lives of patients suffering from bladder and bowel dysfunction. On behalf of all Axonics stakeholders, I extend our sincere appreciation to Mr. Amble and Ms. Bakker.”

About Axonics Modulation Technologies, Inc.

Axonics, based in Irvine, Calif., has developed and is commercializing novel implantable SNM devices for patients with urinary and bowel dysfunction. These conditions are caused by a miscommunication between the bladder and the brain and significantly impacts quality of life. Overactive bladder affects an estimated 87 million adults in the U.S. and Europe. Another estimated 40 million adults are reported to suffer from fecal incontinence/accidental bowel leakage. Axonics SNM therapy, which has been clinically proven to reduce symptoms and restore pelvic floor function, is now being offered at hundreds of medical centers across the U.S. and in dozens of select hospitals in Western Europe. Reimbursement coverage is well established in the U.S. and is a covered service in most European countries. The Axonics System is the first long-lived rechargeable SNM system approved for sale in the world, and the first to gain full-body MRI conditional labeling. For more information, visit www.axonics.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201214005157/en/

Neil Bhalodkar

949-336-5293

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Public Relations/Investor Relations Medical Devices Health Communications Medical Supplies

MEDIA:

Logo

Advanced Energy Continues to Raise the Bar in Configurable Power Supplies With New CoolX^®3000

CoolX3000 provides highest performance, unique flexibility and intelligent control and monitoring for medical, life science and specialized industrial applications

DENVER–(BUSINESS WIRE)–Advanced Energy Industries, Inc. (Nasdaq: AEIS) – a global leader in highly engineered, precision power conversion, measurement and control solutions – today introduced its new Excelsys CoolX^®3000 modular, configurable power platform. Designed for a wide range of demanding medical and industrial applications, this 3000 W power supply platform delivers leading power density, provides unique flexibility, and features digital communication and control to connect with other applications to deliver on the promise of Industry 4.0.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201214005134/en/

Optimized for use in medical diagnostics, imaging and treatment equipment, life science systems, clinical chemistry as well as specialized industrial equipment, the CoolX3000 rounds out AE’s CoolX family of configurable power supplies, which includes the CX600, CX1000 and CX1800 Series.

CoolX3000 simplifies system integration for the world’s leading OEMs and provides unique levels of flexibility and scalability, with up to 24 isolated user field-configurable outputs and individual output controls. The CoolX3000 provides the highest power level in the range, offering full control of output voltage and current, as well as sequencing control via digital and analog interfaces. Further, CoolX3000 has full safety agency approval for operation in high altitude conditions of up to 5,000 meters, which is critical for medical applications.

“The CoolX3000 builds on Advanced Energy’s market-leading CoolX family of configurable power supplies and provides our medical, life science and industrial customers with a broader range of power, outputs and intelligent control capabilities to meet their design requirements,” said Conor Duffy, vice president and general manager, medical, at Advanced Energy. “For decades, customers have relied on AE’s line of highly reliable and extremely efficient power solutions. We are future-proofing our customers’ systems with the latest, advanced regulatory and safety approvals. With full digital communication and control, we are also a partner in enabling their Industry 4.0 initiatives.”

CoolX3000 meets the industry’s latest medical and industrial safety standards, including IEC60601-1 3rd edition, IEC60601-1-2 4th edition (EMC), IEC60950, IEC62368-1 and SEMI F47.

For detailed product information and technical specifications, visit the CoolX3000 product page.

About Advanced Energy

Advanced Energy (Nasdaq: AEIS) is a global leader in the design and manufacturing of highly engineered, precision power conversion, measurement and control solutions for mission-critical applications and processes. AE’s power solutions enable customer innovation in complex applications for a wide range of industries including semiconductor equipment, industrial, manufacturing, telecommunications, data center computing and healthcare. With engineering know-how and responsive service and support around the globe, the company builds collaborative partnerships to meet technology advances, propel growth for its customers and innovate the future of power. Advanced Energy has devoted more than three decades to perfecting power for its global customers and is headquartered in Denver, Colorado, USA. For more information, visit www.advancedenergy.com.

Advanced Energy | Precision. Power. Performance.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201214005134/en/

For press inquiries, contact:

Lora Wilson / Valerie Christopherson

Global Results Communications for Advanced Energy Industries, Inc.

[email protected]

+1 949.306.0276

KEYWORDS: Colorado United States North America

INDUSTRY KEYWORDS: Technology Manufacturing Other Health Health Semiconductor Other Energy Other Manufacturing Alternative Energy Energy Engineering Hardware

MEDIA:

Logo

Photo

Advanced Energy’s new Excelsys CoolX3000 modular, configurable power platform is designed for a wide range of demanding medical and industrial applications. This 3000 W power supply platform delivers leading power density, provides unique flexibility, and features digital communication and control to connect with other applications to deliver on the promise of Industry 4.0. (Photo: Business Wire)

Liberty Broadband and GCI Liberty Announce Receipt of Approvals from the Regulatory Commission of Alaska

ENGLEWOOD, Colo.–(BUSINESS WIRE)–
Liberty Broadband Corporation (“Liberty Broadband”) (NASDAQ: LBRDA, LBRDK) and GCI Liberty, Inc. (“GCI Liberty”) (NASDAQ: GLIBA, GLIBP) announced today that the Regulatory Commission of Alaska (“RCA”) has granted Liberty Broadband’s applications to acquire an indirect controlling interest in certain subsidiaries of GCI Liberty that hold certificates of public convenience and necessity issued by the RCA. As a result, Liberty Broadband and GCI Liberty have received all regulatory approvals required to complete the planned merger between the companies (“the Combination”). Liberty Broadband and GCI Liberty expect the Combination to close promptly following the receipt of required stockholder approvals.

About Liberty Broadband

Liberty Broadband Corporation’s (NASDAQ: LBRDA, LBRDK) businesses consist of its interest in Charter Communications and its subsidiary Skyhook.

About GCI Liberty, Inc.

GCI Liberty, Inc. (Nasdaq: GLIBA, GLIBP) operates and owns interests in a broad range of communications businesses. GCI Liberty’s assets consist of its subsidiary GCI Holdings, LLC (“GCI”) and interests in Charter Communications and Liberty Broadband. GCI is Alaska’s largest communications provider, providing data, wireless, video, voice and managed services to consumer and business customers throughout Alaska and nationwide. GCI has delivered services for nearly 40 years to some of the most remote communities and in some of the most challenging conditions in North America.

Forward-Looking Statements

This communication includes forward-looking statements. All statements other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws. These forward-looking statements generally can be identified by phrases such as “expects” or other words or phrases of similar import or future or conditional verbs such as “will,” “may,” “might,” “should,” “would,” “could,” or similar variations. Similarly, statements about the Combination, including satisfaction of conditions to the Combination and the timing of the Combination and other statements that are not historical facts are also forward-looking statements. It is uncertain whether any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do, what impact they will have on the results of operations and financial condition of the combined companies or the price of Liberty Broadband or GCI Liberty stock. These forward-looking statements involve certain risks and uncertainties, many of which are beyond the parties’ control, that could cause actual results to differ materially from those indicated in such forward-looking statements, including, but not limited to, the ability of the parties to consummate the Combination on a timely basis or at all and the satisfaction of the conditions precedent to consummation of the Combination, including, but not limited to, approval by the stockholders of Liberty Broadband and GCI Liberty. These forward-looking statements speak only as of the date of this communication, and Liberty Broadband expressly disclaims any obligation or undertaking to disseminate any updates or revisions to any forward-looking statement contained herein to reflect any change in Liberty Broadband’s or GCI Liberty’s expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. Please refer to the publicly filed documents of Liberty Broadband and GCI Liberty, including the most recent Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, for additional information about Liberty Broadband and GCI Liberty and about the risks and uncertainties related to the businesses of Liberty Broadband and GCI Liberty which may affect the statements made in this communication.

Additional Information

Nothing in this communication shall constitute a solicitation to buy or an offer to sell any securities of Liberty Broadband or GCI Liberty, nor shall it constitute an offer, solicitation, or any sale in any jurisdiction in which such offer, solicitation, or sale is unlawful. The offer and sale of shares in the Combination will only be made pursuant to Liberty Broadband’s effective registration statement. Liberty Broadband’s stockholders, GCI Liberty’s stockholders and other investors are urged to read the joint proxy statement/prospectus included in the registration statement on Form S-4 filed regarding the Combination and any other relevant documents filed with the SEC, as well as any amendments or supplements to those documents, because they will contain important information about the Combination. Copies of these SEC filings are available free of charge at the SEC’s website (http://www.sec.gov). Copies of the filings together with the materials incorporated by reference therein are also available, without charge, by directing a request to Liberty Broadband, 12300 Liberty Boulevard, Englewood, Colorado 80112, Attention: Investor Relations, Telephone: (720) 875-5700 or to GCI Liberty, Inc., 12300 Liberty Boulevard, Englewood, Colorado 80112, Attention: Investor Relations, Telephone: (720) 875-5900.

Participants in the Solicitation

Liberty Broadband and GCI Liberty and their respective directors and executive officers and other persons may be deemed to be participants in the solicitation of proxies in respect of the Combination. Information about Liberty Broadband’s directors and executive officers is available in Liberty Broadband’s definitive proxy statement for its 2020 annual meeting of stockholders, which was filed with the SEC on April 10, 2020. Information about GCI Liberty’s directors and executive officers is available in GCI Liberty’s definitive proxy statement for its 2020 annual meeting of stockholders, which was filed with the SEC on April 10, 2020. Other information regarding the participants in the proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, are contained in the joint proxy statement/prospectus included in the registration statement on Form S-4 filed with the SEC and other relevant materials to be filed with the SEC, as well as any amendments or supplements to those documents, regarding the Combination when they become available. Investors should read the joint proxy statement/prospectus included in the registration statement on Form S-4 carefully before making any voting or investment decisions. You may obtain free copies of these documents from Liberty Broadband and GCI Liberty as indicated above.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201214005162/en/

Liberty Broadband Corporation

Courtnee Chun, 720-875-5420

GCI Liberty, Inc.

Courtnee Chun, 720-875-5420

KEYWORDS: Alaska Colorado United States North America

INDUSTRY KEYWORDS: Technology Communications Other Communications Telecommunications

MEDIA:

Logo

AtriCure to Participate in the 39^th Annual J.P. Morgan Healthcare Conference

MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that the company will be participating in the upcoming 39^th Annual J.P. Morgan Healthcare Conference being held virtually.

AtriCure’s management is scheduled to present on Monday, January 11, 2021, at 10:00 a.m. Eastern Time. Interested parties may access a live audio webcast of the presentation by visiting the “Investors” section of the company’s website at https://ir.atricure.com.

AtriCure’s management is also scheduled to participate in one-on-one investor meetings in a virtual setting at the Needham Annual Growth Conference on Thursday, January 14, 2021. Due to the format of this event, no webcast will be available.

About AtriCure

AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator^® Synergy™ Ablation System is the first and only medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip^® Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide. For more information, visit AtriCure.com or follow us on Twitter @AtriCure.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201214005105/en/

Angie Wirick

AtriCure, Inc.

Chief Financial Officer

(513) 755-5334

[email protected]

Lynn Pieper Lewis

Gilmartin Group

Investor Relations

(415) 937-5402

[email protected]

KEYWORDS: United States North America Ohio

INDUSTRY KEYWORDS: Surgery Medical Devices Hospitals Health Cardiology

MEDIA:

Logo

Avaya Earns Frost & Sullivan Award for Excellence in Healthcare Solutions

Competitive Strategy Leadership Award Recognizes Avaya’s Extensive Portfolio and Overall Ability to Improve Patient Care and Engagement

RALEIGH-DURHAM, N.C.–(BUSINESS WIRE)–Avaya (NYSE: AVYA), a global leader in solutions to enhance and simplify communications and collaboration, today announced it has earned Frost & Sullivan’s Competitive Strategy Leadership Award for its extensive portfolio of Avaya OneCloud healthcare solutions.

The firm recognized Avaya based on its healthcare-specific portfolio of solutions capable of being adapted to a wide range of healthcare use cases, along with its ability to assess and respond to the industry’s particular requirements. The company’s global footprint, strong brand and track record, and possession of the necessary know-how to quickly adapt to a rapidly-changing environment placed Avaya in a position that very few other organizations can claim.

“We are proud of the role our healthcare solutions play in enhancing the experience for patients, families, care teams and all others that touch the patient journey. Avaya enables healthcare organizations to engage across the care continuum delivering experiences that matter when they truly matter most,” said Tara Mahoney, Global Healthcare Practice Leader, Avaya. “Many of our healthcare customers are pursuing digital transformation to adapt as health systems are faced with unprecedented pressure to support patients under extreme resource constraints, especially during the pandemic. By connecting people, resources, data, and more, Avaya is helping customers optimize their operations and reduce risk while strengthening the level of care they can provide to patients and customers. We are very pleased to receive this recognition from Frost & Sullivan and will continue to drive innovation and positive outcomes for our healthcare clients.”

Healthcare providers across all facets of the industry are a priority for Avaya, and the company works with 80 percent of the Health and Life Sciences Fortune 500 Companies, and 12 of the top 20 U.S. hospitals rely on Avaya OneCloud communications solutions, including Avaya Spaces and Avaya OneCloud CPaaS. Avaya solutions for Healthcare include:

Care Team Collaboration

• Improve care coordination with mobile collaboration across the entire health system
• Increase time with patients by enabling the care team to engage with the right resource by name, patient assignment or role
• Ensure collaboration is integrated into clinical workflows and applications for improved patient quality and experience

Patient Access & Services

• Improve the patient experience with a rich multi-touchpoint solution driving improved access, revenue cycle and care plan adherence.
• Reduce no-shows and leakage and improve pre- and post-procedure instructions by leveraging automation, proactive engagement and digital deflection in communicating with patients.
• Allow patient representatives to focus on the most critical patient inquiries through automation and digital deflection of more routine inquiries and communications.
• Leverage integrations with EHR, business applications, customer portals for contextual communications with patients and members.

Virtual Care

• Reduce avoidable emergent and urgent care and better manage population health through telehealth triage.
• Improve quality metrics and staff efficiencies with remote monitoring, bedside consult and virtual rounding on industry-leading video devices and cloud collaboration.
• Deliver provider, patient and scheduler tools and workflows truly needed for one-click virtual visits for physician and mental wellness.
• Improve home and end-of-life care with immersive collaboration with the patient, family and entire care team in the home and remotely.

“Avaya stands out among communications and collaboration providers with its ability to address a broad spectrum of customer needs and requirements within the healthcare vertical industry,” said Elka Popova, VP, Information & Communications Technologies, Frost & Sullivan. “From on-premise and cloud-based communications, collaboration and customer experience solutions, to a wide range of devices, professional services and programmable capabilities, Avaya brings a comprehensive portfolio to help optimize important workflows within healthcare organizations. As the healthcare vertical prepares for the era of digital sustainability, Avaya is well positioned to become the partner of choice for healthcare providers at any stage of their digital transformation journey.”

Avaya recently earned the 2020 Pandemic Tech Innovation Award for Exceptional Innovation, recognizing its solutions for helping society and business function effectively in the face of challenges caused by the global COVID-19 pandemic. Additionally, TrustRadius selected Avaya for the 2020 Tech Cares Award for going above and beyond to provide global communities, clients, and frontline workers with support during the COVID-19 crisis.

Further information about Frost & Sullivan’s Research Methodology can be found here.

Additional Resources

• Find more information about Avaya’s healthcare solutions
• Learn more about Delivering Excellent Communications and Collaboration Experiences in Healthcare
• Read the full report from Frost & Sullivan
• Learn how to solve today and tomorrow’s healthcare communication challenges
• Read our blog, Experts Share How to Create an Effective Contact Tracing Program
• The Crisis Within a Crisis: How to Steer Your Health Systems’ Communications During and After COVID-19, learn more
• Check out a recent blog on Becker’s Health IT, The consumer-driven technology that could be the cure to healthcare’s patient access problem

About Avaya

Businesses are built by the experiences they provide, and everyday millions of those experiences are delivered by Avaya Holdings Corp. (NYSE: AVYA). Avaya is shaping what’s next for the future of work, with innovation and partnerships that deliver game-changing business benefits. Our cloud communications solutions and multi-cloud application ecosystem power personalized, intelligent, and effortless customer and employee experiences to help achieve strategic ambitions and desired outcomes. Together, we are committed to help grow your business by delivering Experiences that Matter. Learn more at http://www.avaya.com.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today’s market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector, and the investment community.

Cautionary Note Regarding Forward-Looking Statements

This document contains certain “forward-looking statements.” All statements other than statements of historical fact are “forward-looking” statements for purposes of the U.S. federal and state securities laws. These statements may be identified by the use of forward looking terminology such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “our vision,” “plan,” “potential,” “preliminary,” “predict,” “should,” “will,” or “would” or the negative thereof or other variations thereof or comparable terminology. The Company has based these forward-looking statements on its current expectations, assumptions, estimates and projections. While the Company believes these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond its control. The factors are discussed in the Company’s Annual Report on Form 10-K and subsequent quarterly reports on Form 10-Q filed with the Securities and Exchange Commission (the “SEC”) available at www.sec.gov, and may cause the Company’s actual results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by these forward-looking statements. The Company cautions you that the list of important factors included in the Company’s SEC filings may not contain all of the material factors that are important to you. In addition, in light of these risks and uncertainties, the matters referred to in the forward-looking statements contained in this press release may not in fact occur. The Company undertakes no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.

Source: Avaya Newsroom

View source version on businesswire.com: https://www.businesswire.com/news/home/20201214005136/en/

For Media Inquiries:

Alex Alias

[email protected]

 

KEYWORDS: North Carolina United States North America

INDUSTRY KEYWORDS: Data Management Technology VoIP Telecommunications Software Internet

MEDIA:

Logo

Wabtec Declares Regular Quarterly Common Dividend

PITTSBURGH–(BUSINESS WIRE)–
Wabtec Corporation (NYSE: WAB) announced today that its Board of Directors declared a regular quarterly common dividend of 12 cents per share, payable on February 26, 2021 to holders of record on February 12, 2021.

About Wabtec Corporation

Wabtec Corporation is a leading global provider of equipment, systems, digital solutions and value-added services for freight and transit rail. Drawing on nearly four centuries of collective experience across Wabtec, GE Transportation and Faiveley Transport, the company has unmatched digital expertise, technological innovation, and world-class manufacturing and services, enabling the digital-rail-and-transit ecosystems. Wabtec is focused on performance that drives progress, creating transportation solutions that move and improve the world. The freight portfolio features a comprehensive line of locomotives, software applications and a broad selection of mission-critical controls systems, including Positive Train Control (PTC). The transit portfolio provides highly engineered systems and services to virtually every major rail transit system around the world, supplying an integrated series of components for buses and all train-related market segments that deliver safety, efficiency and passenger comfort. Along with its industry-leading portfolio of products and solutions for the rail and transit industries, Wabtec is a leader in mining, marine and industrial solutions. Visit: www.WabtecCorp.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201214005027/en/

Wabtec Investor Contact

Kristine Kubacki, CFA / [email protected] / 412-450-2033

Wabtec Media Contact

Deia Campanelli / [email protected] / 773-297-0482

KEYWORDS: Pennsylvania United States North America

INDUSTRY KEYWORDS: Rail Technology Transport Logistics/Supply Chain Management Software Hardware

MEDIA:

Posted on December 14, 2020 8:03 am

Strong Retail Sales Performance and Sell Through Result In Regional Grocer Save Mart To Expand cbdMD and Paw CBD Brand Offerings To Additional 100 Locations

Strong Retail Sales Performance and Sell Through Result In Regional Grocer Save Mart To Expand cbdMD and Paw CBD Brand Offerings To Additional 100 Locations

CHARLOTTE, N.C.–(BUSINESS WIRE)–
cbdMD, Inc. (NYSE American: YCBD, YCBD PR A) announced that regional grocer Save Mart has agreed to expand their cbdMD product offerings to additional locations due to strong retail sales performance and sell through of cbdMD and Paw CBD brands.

The Save Mart Companies, a regional grocer which owns and operates stores under the banners of Save Mart, Lucky, Lucky California and FoodMaxx throughout California and Northern Nevada, has expanded their cbdMD and Paw CBD product offerings into 100 additional locations, from the initial five locations.

“Retailers across America are finding that our cbdMD and Paw CBD brands are achieving excellent sell through results and therefore they are expanding our product offerings across their distribution channels,” said Pancho Mangual, EVP of Sales at cbdMD, Inc.

About cbdMD, Inc.

cbdMD, Inc. is a nationally recognized consumer cannabidiol (CBD) brand whose current products include CBD tinctures, CBD capsules, CBD gummies, CBD topicals, CBD bath bombs, and CBD pet products. cbdMD is also a proud partner of Bellator MMA and Life Time, Inc., and has one of the largest rosters of professional sports athletes who are part of “Team cbdMD.” To learn more about cbdMD and our comprehensive line of over 100 SKUs of U.S. produced, non-THC¹ CBD products, please visit www.cbdMD.com, follow cbdMD on Instagram and Facebook, or visit one of the 6,000 retail outlets that carry cbdMD products.

About The Save Mart Companies

The Save Mart Companies operate 206 stores throughout California and Northern Nevada under the banners of FoodMaxx, Lucky, Lucky California and Save Mart. Based in the Central Valley, TSMC is committed to sourcing a wide variety of local products to communities throughout California and Northern Nevada. In addition to its retail operation, the company also operates Smart Refrigerated Transport and is a partner in Super Store Industries (SSI), which owns and operates a distribution center in Lathrop and the Sunnyside Farms dairy processing plant in Turlock. For more information on the company, please visit: www.TheSaveMartCompanies.com.

Forward-Looking Statements

This press release contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified by the use of words such as ”should,” ”may,” ”intends,” ”anticipates,” ”believes,” ”estimates,” ”projects,” ”forecasts,” ”expects,” ”plans,” and ”proposes.” These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements, including, without limitation, statements made with respect to the expansion of the consumer market for CBD products and our ability to increase our market share, challenges related to the impact of the COVID-19 environment, our limited operating history, our ability to expand our business and significantly increase our net sales, our ability to effectively leverage our brand partnerships and sponsorships, our ability to effectively compete in our market, and our ability to report profitable operations in the future. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading “Risk Factors” in cbdMD, Inc.’s Annual Report on Form 10-K for the fiscal year ended September 30, 2019, as amended, and our Quarterly Report on Form 10-Q for the period ended June 30, 2020, both as filed with the Securities and Exchange Commission (the “SEC”) and our other filings with the SEC. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are generally outside the control of cbdMD, Inc. and are difficult to predict. cbdMD, Inc. does not undertake any duty to update any forward-looking statements except as may be required by law. The information which appears on our websites and our social media platforms, including, but not limited to, Instagram and Facebook, is not part of this press release.

______________________________

¹ Non-THC is defined as below the level of detection using validated scientific analytical tools.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201214005023/en/

John Weston

Director of Investor Relations

[email protected]

704-249-9515

KEYWORDS: North Carolina United States North America

INDUSTRY KEYWORDS: Other Consumer Other Retail Supermarket Specialty Alternative Medicine Health Consumer Retail Online Retail

MEDIA:

Logo